Merck KGaA

Dec 01, 03
10:40 ET	Merck KGaA: Erbitux(TM) Cancer Drug Approved and Available in Switzerland
Oct 14, 02
06:41 ET	Merck Generics Unit Considering Its Options After Adverse Court Decision Regarding Generic Prilosec in the U.S.
Jul 08, 02
14:32 ET	Merck KGaA Clarifies That It Has No Association With Merck & Co or Merck-Medco
May 21, 02
12:22 ET	Merck KGaA's Oncology Pipeline Presented At ASCO
Apr 24, 02
01:30 ET	Merck KGaA Reports Satisfying First Quarter, In Line With Expectations
Apr 18, 02
03:01 ET	Merck KGaA Announces New Structure for Pharma Ethicals, Completes Global Management Team
Feb 27, 02
10:32 ET	Merck KGaA in Talks with ImClone Systems Following FDA meeting
Feb 14, 02
01:30 ET	Merck KGaA Reports Best Year in 333-Year History
Jan 30, 02
12:12 ET	Biovation Ltd. Now Represented by its Own Office in the U.S.
Jan 24, 02
12:09 ET	Merck KGaA's European Development Plan for C225 Remains Unchanged
Nov 15, 01
12:07 ET	Functional Nanomaterials: Merck KGaA and NTera Form Strategic Alliance, Sign Commercialisation Agreement
Nov 01, 01
12:02 ET	'A New Look at the Heart in Heart Failure' -- International Symposium Focuses on Latest Concepts in Drugs and Devices
Oct 25, 01
11:18 ET	Merck Reports Yet Another Record-Breaking Quarter
Oct 01, 01
11:13 ET	Merck - A Strong Brand Will Be Unmistakable
Sep 20, 01
11:08 ET	Merck KGaA Welcomes North American Partnership of ImClone And Bristol-Myers Squibb for Development of C225 Cancer Drug
Sep 06, 01
12:16 ET	Full Structure of Key Protein May Lead to Next Generation of Cancer Drugs
Aug 22, 01
11:05 ET	Merck KGaA Sells Minority Stake in Pharmaceutical Resources for More Than EUR 400 million
Aug 08, 01
11:02 ET	Merck KGaA begins Marketing of Metafolin in the United States, Opens New Era in the Field of Dietary-Supplement Ingredients
Jul 26, 01
10:59 ET	Merck KGaA Reports Best Quarter in Its 333-Year History